Vcanbio Cell & Gene Engineering Corp

Vcanbio Cell & Gene Engineering Corp Profit per Employee

The Profit per Employee of Vcanbio Cell & Gene Engineering Corp (600645.SS) as of Oct 18, 2026 is 48,812.71 CNY. In the previous year, Profit per Employee was 43,032.64 CNY — a change of 13.43% (higher).

Profit per Employee

48,812.71CNY

YoY

13.43%

Last updated:

Profit per Employee of Vcanbio Cell & Gene Engineering Corp is 2025 48,812.71 CNY. Profit per Employee of Vcanbio Cell & Gene Engineering Corp was 2024 43,032.64 CNY. It decreases by 13.43% higher compared to the previous year.

The Vcanbio Cell & Gene Engineering Corp Profit per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Profit per Employee
Date
Profit per Employee
Jan 1, 2018
25,408.62 CNY
Jan 1, 2019
21,309.95 CNY
Jan 1, 2020
-54,401.50 CNY
Jan 1, 2021
66,603.81 CNY
Jan 1, 2022
48,450.54 CNY
Jan 1, 2023
45,648.66 CNY
Jan 1, 2024
43,032.64 CNY
Jan 1, 2025
48,812.71 CNY
The Vcanbio Cell & Gene Engineering Corp Profit per Employee history
YEARProfit per EmployeeYoY
48,812.71CNY+13.43%
43,032.64CNY-5.73%
45,648.66CNY-5.78%
48,450.54CNY-27.26%
66,603.81CNY-222.43%
-54,401.50CNY-355.29%
21,309.95CNY-16.13%
25,408.62CNY+471.58%
4,445.34CNY-72.62%
16,234.96CNY-81.83%
89,345.25CNY+487.49%
15,207.97CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Vcanbio Cell & Gene Engineering Corp Stock analysis

What does Vcanbio Cell & Gene Engineering Corp do? Vcanbio Cell & Gene Engineering Corp Ltd is a biotechnology company based in Tianjin, China, operating within the healthcare sector. The company has been publicly traded since its IPO on May 4, 1993, and is listed under the ticker 600645.SS with ISIN CNE000000545. It employs 2,332 full-time staff and focuses on the development of life sciences technology. Vcanbio engages in cell culture, gene detection, and storage services, as well as the production and sale of cytokines culture solutions, cosmetics, and detection reagents. The company primarily serves domestic markets in China, with its headquarters located in Tianjin. Its website is http://www.vcanbio.com. The firm's business activities include the development and application of biotechnology solutions, though specific details on product names, acquisitions, or additional financial figures are not provided in the available information. Vcanbio operates as a public company with a presence in the Chinese biotechnology industry, emphasizing innovation in cell and gene engineering. Vcanbio Cell & Gene Engineering Corp is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vcanbio Cell & Gene Engineering Corp stock

Profit per Employee of Vcanbio Cell & Gene Engineering Corp is 48,812.71 CNY in 2025.

Profit per Employee of Vcanbio Cell & Gene Engineering Corp changed from 43,032.64 CNY to 48,812.71 CNY, representing a 13.43% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Profit per Employee Vcanbio Cell & Gene Engineering Corp since 2006 – with annual values, charts, and detailed analysis.

Profit per employee measures how much net income each employee generates on average. It is a key indicator of workforce efficiency.

Profit per Employee's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Profit per Employee's Vcanbio Cell & Gene Engineering Corp historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Workforce — Vcanbio Cell & Gene Engineering Corp

EmployeesRevenue per EmployeeProfit per EmployeeMarket Cap per EmployeeEBIT per EmployeeEBITDA per EmployeeR&D per EmployeePP&E per Employee

All Key Metrics — Vcanbio Cell & Gene Engineering Corp